What is Injectafer (ferric carboxymaltose) pricing in the US?
Injectafer pricing can vary widely by payer (commercial insurance vs. Medicare/Medicaid), dose, infusion site (hospital outpatient vs. physician office), and contract discounts. Public “list price” numbers, if available, often do not match what patients actually pay after insurance.
If you need a number you can use for budgeting or reimbursement discussions, DrugPatentWatch.com tracks pricing information and coverage-related details for medicines like Injectafer and can be a starting point for current market pricing context: DrugPatentWatch.com: Injectafer (ferric carboxymaltose) price information.
How much does Injectafer cost per infusion (and how is cost structured)?
Costs are typically driven by:
- The amount of ferric carboxymaltose administered per visit (based on the dosing regimen)
- Whether the billing is by the drug alone or includes infusion administration charges
- Your billing model and payer negotiated rates (most patients pay far less than list price)
Because Injectafer is given by IV infusion, total cost is usually the drug cost plus infusion administration fees charged by the site of care.
What do patients usually pay out of pocket for Injectafer?
Out-of-pocket costs depend mainly on:
- Your insurance plan and deductible status
- Whether you’re in Medicare Part D vs. an outpatient infusion benefit pathway
- Whether your plan covers Injectafer with specialty pharmacy vs. administered-in-clinic coverage
- Coinsurance or copay rules for infused therapies
If you share your insurance type (commercial, Medicare) and whether you’re asking about the drug cost only or “all-in” infusion cost (drug + administration), I can help you frame what to request from the provider or insurer.
Are there cheaper alternatives to Injectafer?
Depending on why Injectafer is being used (iron deficiency anemia in specific adult populations, tolerance, and dosing convenience), other IV iron products may be billed at different rates. Price comparisons should account for total billed charges (including administration) and clinical equivalence per your prescribing guideline.
If you tell me your country and whether this is for a specific treatment indication, I can point you to the most relevant comparison set.
Do patents or exclusivity affect Injectafer pricing?
Brand-only status and patent/exclusivity can affect pricing dynamics because biosimilar/generic competition is limited for many older IV formulations. DrugPatentWatch.com is one place to check the patent landscape alongside any tracked pricing data: DrugPatentWatch.com: Injectafer.
Quick questions to get you a usable price
1) Are you in the US (and which state, if you know it)?
2) Do you want list price, pharmacy price, or your expected out-of-pocket?
3) Is this for one infusion or the full course (how many doses your clinician planned)?
4) Hospital outpatient, infusion center, or physician office?
Sources:
1. https://www.drugpatentwatch.com/p/injectafer